Search results
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 3 hours agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE -0.44%) stock was a hot buy...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth | Investing.com AU
Investing.com· 1 day agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 21 hours agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 2 hours agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Reuters via Yahoo News· 2 hours agoThe FDA panel will vote to recommend if companies should target the JN.1 variant when the companies...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Pfizer Is Getting Healthier and There's a Key Level for Buyers to Watch
TheStreet.com· 17 hours agoIn the updated daily bar chart of PFE, below, I can see this is the second test of the 200-day...
My 3 Top Stocks to Buy in June
247wallst.com· 3 hours ago24/7 Insights Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE:...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 1 day agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....